186 related articles for article (PubMed ID: 33432319)
21. Left ventricular involvement assessed by LGE-CMR in predicting the risk of adverse outcomes of arrhythmogenic cardiomyopathy with ICDs.
Zhang N; Song Y; Hua W; Hu Y; Chen L; Cai M; Niu H; Cai C; Gu M; Zhao S; Zhang S
Int J Cardiol; 2021 Aug; 337():79-85. PubMed ID: 33839174
[TBL] [Abstract][Full Text] [Related]
22. The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation .
Neilan TG; Shah RV; Abbasi SA; Farhad H; Groarke JD; Dodson JA; Coelho-Filho O; McMullan CJ; Heydari B; Michaud GF; John RM; van der Geest R; Steigner ML; Blankstein R; Jerosch-Herold M; Kwong RY
J Am Coll Cardiol; 2013 Dec; 62(23):2205-14. PubMed ID: 23994399
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis.
Rajesh GN; Thottian JJ; Subramaniam G; Desabandhu V; Sajeev CG; Krishnan MN
Indian Heart J; 2017; 69(6):742-750. PubMed ID: 29174252
[TBL] [Abstract][Full Text] [Related]
24. Feature-Tracking Global Longitudinal Strain Predicts Death in a Multicenter Population of Patients With Ischemic and Nonischemic Dilated Cardiomyopathy Incremental to Ejection Fraction and Late Gadolinium Enhancement.
Romano S; Judd RM; Kim RJ; Kim HW; Klem I; Heitner JF; Shah DJ; Jue J; White BE; Indorkar R; Shenoy C; Farzaneh-Far A
JACC Cardiovasc Imaging; 2018 Oct; 11(10):1419-1429. PubMed ID: 29361479
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of multiple cardiac magnetic resonance imaging parameters in patients with idiopathic dilated cardiomyopathy.
Fu H; Wen L; Xu H; Liu H; Xu R; Xie L; Sun R; Zhang K; Zhang L; Yang Z; Guo Y
Int J Cardiol; 2021 Feb; 325():89-95. PubMed ID: 33038407
[TBL] [Abstract][Full Text] [Related]
26. [Late gadolinium enhancement distribution pattern of left ventricular wall in patients with dilated cardiomyopathy: a preliminary study].
Li R; Cui C; Lan T; Chen XY; Yin G; Lu MJ; Zhao SH
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Nov; 48(11):922-929. PubMed ID: 33210863
[No Abstract] [Full Text] [Related]
27. Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis.
Kuruvilla S; Adenaw N; Katwal AB; Lipinski MJ; Kramer CM; Salerno M
Circ Cardiovasc Imaging; 2014 Mar; 7(2):250-258. PubMed ID: 24363358
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
[TBL] [Abstract][Full Text] [Related]
29. Absence of late gadolinium enhancement on cardiac magnetic resonance imaging in ventricular fibrillation and nonischemic cardiomyopathy.
Voskoboinik A; Wong MCG; Elliott JK; Costello BT; Prabhu S; Mariani JA; Kalman JM; Kistler PM; Taylor AJ; Morton JB
Pacing Clin Electrophysiol; 2018 Sep; 41(9):1109-1115. PubMed ID: 29931686
[TBL] [Abstract][Full Text] [Related]
30. Pattern of late gadolinium enhancement predicts arrhythmic events in patients with non-ischemic cardiomyopathy.
Shin DG; Lee HJ; Park J; Uhm JS; Pak HN; Lee MH; Kim YJ; Joung B
Int J Cardiol; 2016 Nov; 222():9-15. PubMed ID: 27458824
[TBL] [Abstract][Full Text] [Related]
31. Detecting cardiac involvement with magnetic resonance in patients with active eosinophilic granulomatosis with polyangiitis.
Yune S; Choi DC; Lee BJ; Lee JY; Jeon ES; Kim SM; Choe YH
Int J Cardiovasc Imaging; 2016 Jun; 32 Suppl 1():155-62. PubMed ID: 26831057
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of CMR in patients presenting with ventricular arrhythmias.
Dawson DK; Hawlisch K; Prescott G; Roussin I; Di Pietro E; Deac M; Wong J; Frenneaux MP; Pennell DJ; Prasad SK
JACC Cardiovasc Imaging; 2013 Mar; 6(3):335-44. PubMed ID: 23433931
[TBL] [Abstract][Full Text] [Related]
33. CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: an international Registry.
Guaricci AI; Masci PG; Muscogiuri G; Guglielmo M; Baggiano A; Fusini L; Lorenzoni V; Martini C; Andreini D; Pavon AG; Aquaro GD; Barison A; Todiere G; Rabbat MG; Tat E; Raineri C; Valentini A; Varga-Szemes A; Schoepf UJ; De Cecco CN; Bogaert J; Dobrovie M; Symons R; Focardi M; Gismondi A; Lozano-Torres J; Rodriguez-Palomares JF; Lanzillo C; Di Roma M; Moro C; Di Giovine G; Margonato D; De Lazzari M; Perazzolo Marra M; Nese A; Casavecchia G; Gravina M; Marzo F; Carigi S; Pica S; Lombardi M; Censi S; Squeri A; Palumbo A; Gaibazzi N; Camastra G; Sbarbati S; Pedrotti P; Masi A; Carrabba N; Pradella S; Timpani M; Cicala G; Presicci C; Puglisi S; Sverzellati N; Santobuono VE; Pepi M; Schwitter J; Pontone G
Europace; 2021 Jul; 23(7):1072-1083. PubMed ID: 33792661
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
[TBL] [Abstract][Full Text] [Related]
35. Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis.
Ammirati E; Moroni F; Sormani P; Peritore A; Milazzo A; Quattrocchi G; Cipriani M; Oliva F; Giannattasio C; Frigerio M; Roghi A; Camici PG; Pedrotti P
Int J Cardiol; 2017 Mar; 231():216-221. PubMed ID: 27913009
[TBL] [Abstract][Full Text] [Related]
36. Cardiac MR With Late Gadolinium Enhancement in Acute Myocarditis With Preserved Systolic Function: ITAMY Study.
Aquaro GD; Perfetti M; Camastra G; Monti L; Dellegrottaglie S; Moro C; Pepe A; Todiere G; Lanzillo C; Scatteia A; Di Roma M; Pontone G; Perazzolo Marra M; Barison A; Di Bella G;
J Am Coll Cardiol; 2017 Oct; 70(16):1977-1987. PubMed ID: 29025554
[TBL] [Abstract][Full Text] [Related]
37. Optimal timing of follow-up cardiac magnetic resonance in patients with uncomplicated acute myocarditis.
Pieroni M; Ciabatti M; Zocchi C; Tavanti V; Camporeale A; Saletti E; Fumagalli C; Venezia D; Lombardi M; Olivotto I; Bolognese L
Int J Cardiol; 2024 Feb; 397():131603. PubMed ID: 37979787
[TBL] [Abstract][Full Text] [Related]
38. Clinical and CMR characteristics associated with cardiac events in patients with Fabry disease.
Hiestand R; Nowak A; Sokolska JM; Chan R; Ruschitzka F; Manka R; Gruner C
Int J Cardiol; 2023 Jul; 382():46-51. PubMed ID: 37044180
[TBL] [Abstract][Full Text] [Related]
39. Additive prognostic value of red cell distribution width over late gadolinium enhancement on CMR in patients with non-ischemic dilated cardiomyopathy.
Yi JE; Lee HJ; Kim YJ; Kim Y; Joung B; Park J
Sci Rep; 2020 Jun; 10(1):9212. PubMed ID: 32513998
[TBL] [Abstract][Full Text] [Related]
40. Progression of Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Cardiac Magnetic Resonance Study.
Habib M; Adler A; Fardfini K; Hoss S; Hanneman K; Rowin EJ; Maron MS; Maron BJ; Rakowski H; Chan RH
JACC Cardiovasc Imaging; 2021 May; 14(5):947-958. PubMed ID: 33248971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
